Showing results (11-20 of 40) with videos related to
Sort By:
Pageof 4
Regulatory Toxicology and Pharmacology : RTP|December 11, 2002
Population distribution of aldehyde dehydrogenase-2 genetic polymorphism: implications for risk assessmentGary Ginsberg, Susan Smolenski, Dale Hattis, et al.Journal of Toxicology and Environmental Health. Part A|January 10, 2004
Physiologically based pharmacokinetic (PBPK) modeling of caffeine and theophylline in neonates and adults: implications for assessing children's risks from environmental agentsGary Ginsberg, Dale Hattis, Abel Russ, et al.Journal of Toxicology and Environmental Health. Part A|December 1, 2007
Approaches to acrylamide physiologically based toxicokinetic modeling for exploring child-adult dosimetry differencesKatherine Walker, Dale Hattis, Abel Russ, et al.Archives of Toxicology|March 6, 2002
Toxicokinetic interaction of 2,5-hexanedione and methyl ethyl ketoneRong Chun Yu, Dale Hattis, Elliot M Landaw, et al.Risk Analysis : an Official Publication of the Society for Risk Analysis|April 26, 2013
Risk assessment can be a game-changing information technology--but too often it isn'tRobert Goble, Vicki M BierJournal of Toxicology and Environmental Health. Part B, Critical Reviews|February 26, 2010
Genetic polymorphism in CYP2E1: Population distribution of CYP2E1 activityPat Neafsey, Gary Ginsberg, Dale Hattis, et al.Journal of Toxicology and Environmental Health. Part B, Critical Reviews|February 26, 2010
Genetic polymorphism in N-Acetyltransferase (NAT): Population distribution of NAT1 and NAT2 activityKaty Walker, Gary Ginsberg, Dale Hattis, et al.Journal of Toxicology and Environmental Health. Part B, Critical Reviews|February 26, 2010
Genetic polymorphism in paraoxonase 1 (PON1): Population distribution of PON1 activityGary Ginsberg, Patricia Neafsey, Dale Hattis, et al.Risk Analysis : an Official Publication of the Society for Risk Analysis|April 17, 2018
Two Types of Vigilance Are Essential to Effective Hazard Management: Maintaining Both Together Is DifficultRobert Goble, Vicki Bier, Ortwin RennRisk Analysis : an Official Publication of the Society for Risk Analysis|March 15, 2003
Differences in pharmacokinetics between children and adults--II. Children's variability in drug elimination half-lives and in some parameters needed for physiologically-based pharmacokinetic modelingDale Hattis, Gary Ginsberg, Bob Sonawane, et al.Pageof 4